KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2025)

Repligen (RGEN) has disclosed Gains from Sales and Divestitures for 7 consecutive years, with $156115.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 5.18% to $156115.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $156115.0, a 5.18% increase, with the full-year FY2025 number at $156115.0, up 5.18% from a year prior.
  • Gains from Sales and Divestitures was $156115.0 for Q4 2025 at Repligen, up from $139681.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $212329.0 in Q4 2021 to a low of $98246.0 in Q1 2024.
  • A 5-year average of $154632.4 and a median of $152272.0 in 2024 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: dropped 24.14% in 2024, then rose 5.18% in 2025.
  • Repligen's Gains from Sales and Divestitures stood at $212329.0 in 2021, then decreased by 1.79% to $208531.0 in 2022, then fell by 6.17% to $195672.0 in 2023, then decreased by 24.14% to $148429.0 in 2024, then increased by 5.18% to $156115.0 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Gains from Sales and Divestitures are $156115.0 (Q4 2025), $139681.0 (Q3 2025), and $122517.0 (Q2 2025).